These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 21673580)

  • 21. Spinal muscular atrophy carrier screening by multiplex polymerase chain reaction using dried blood spot on filter paper.
    Majumdar R; Rehana Z; Al Jumah M; Fetaini N
    Ann Hum Genet; 2005 Mar; 69(Pt 2):216-21. PubMed ID: 15720302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical phenotypes of spinal muscular atrophy patients with hybrid SMN gene.
    Niba ETE; Nishio H; Wijaya YOS; Lai PS; Tozawa T; Chiyonobu T; Yamadera M; Okamoto K; Awano H; Takeshima Y; Saito T; Shinohara M
    Brain Dev; 2021 Feb; 43(2):294-302. PubMed ID: 33036822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation analysis of 419 family and prenatal diagnosis of 339 cases of spinal muscular atrophy in China.
    Sun Y; Kong X; Zhao Z; Zhao X
    BMC Med Genet; 2020 Jun; 21(1):133. PubMed ID: 32552676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experience with the use of risdiplam in a familial case of spinal muscular atrophy 5q in patients with a homozygous deletion of the SMN1 gene and the same copy number of the SMN2 gene].
    Novikova ES
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(5):138-141. PubMed ID: 38884441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trinucleotide insertion in the SMN2 promoter may not be related to the clinical phenotype of SMA.
    Harahap NI; Takeuchi A; Yusoff S; Tominaga K; Okinaga T; Kitai Y; Takarada T; Kubo Y; Saito K; Sa'adah N; Nurputra DK; Nishimura N; Saito T; Nishio H
    Brain Dev; 2015 Aug; 37(7):669-76. PubMed ID: 25459970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spinal Muscular Atrophy: New Screening System with Real-Time mCOP-PCR and PCR-RFLP for SMN1 Deletion.
    Niba ETE; Rochmah MA; Harahap NIF; Awano H; Morioka I; Iijima K; Takeshima Y; Saito T; Saito K; Takeuchi A; Lai PS; Bouike Y; Matsuo M; Nishio H; Shinohara M
    Kobe J Med Sci; 2019 Jul; 65(2):E44-E48. PubMed ID: 31956255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between SMN2 copy number and clinical phenotype of spinal muscular atrophy: three SMN2 copies fail to rescue some patients from the disease severity.
    Harada Y; Sutomo R; Sadewa AH; Akutsu T; Takeshima Y; Wada H; Matsuo M; Nishio H
    J Neurol; 2002 Sep; 249(9):1211-9. PubMed ID: 12242541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spinal Muscular Atrophy: Advanced Version of Screening System with Real-Time mCOP-PCR and PCR-RFLP for SMN1 Deletion.
    Niba ETE; Rochmah MA; Harahap NIF; Awano H; Morioka I; Iijima K; Takeshima Y; Saito T; Saito K; Takeuchi A; Lai PS; Bouike Y; Matsuo M; Nishio H; Shinohara M
    Kobe J Med Sci; 2019 Jul; 65(2):E49-E53. PubMed ID: 31956256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid diagnosis of spinal muscular atrophy using tetra-primer ARMS PCR assay: simultaneous detection of SMN1 and SMN2 deletion.
    Baris I; Etlik O; Koksal V; Arican-Baris ST
    Mol Cell Probes; 2010 Jun; 24(3):138-41. PubMed ID: 20025960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of SMN1 to SMN2 gene conversion events and partial SMN1 gene deletions using array digital PCR.
    Stabley DL; Holbrook J; Scavina M; Crawford TO; Swoboda KJ; Robbins KM; Butchbach MER
    Neurogenetics; 2021 Mar; 22(1):53-64. PubMed ID: 33415588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spinal muscular atrophy caused by a novel Alu-mediated deletion of exons 2a-5 in SMN1 undetectable with routine genetic testing.
    Jedličková I; Přistoupilová A; Nosková L; Majer F; Stránecký V; Hartmannová H; Hodaňová K; Trešlová H; Hýblová M; Solár P; Minárik G; Giertlová M; Kmoch S
    Mol Genet Genomic Med; 2020 Jul; 8(7):e1238. PubMed ID: 32337852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multisite Evaluation and Validation of a Sensitive Diagnostic and Screening System for Spinal Muscular Atrophy that Reports SMN1 and SMN2 Copy Number, along with Disease Modifier and Gene Duplication Variants.
    Milligan JN; Larson JL; Filipovic-Sadic S; Laosinchai-Wolf W; Huang YW; Ko TM; Abbott KM; Lemmink HH; Toivonen M; Schleutker J; Gentile C; Van Deerlin VM; Zhu H; Latham GJ
    J Mol Diagn; 2021 Jun; 23(6):753-764. PubMed ID: 33798739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lower incidence of deletions in the survival of motor neuron gene and the neuronal apoptosis inhibitory protein gene in children with spinal muscular atrophy from Serbia.
    Miskovic M; Lalic T; Radivojevic D; Cirkovic S; Vlahovic G; Zamurovic D; Guc-Scekic M
    Tohoku J Exp Med; 2011 Nov; 225(3):153-9. PubMed ID: 21971302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The analysis of the association between the copy numbers of survival motor neuron gene 2 and neuronal apoptosis inhibitory protein genes and the clinical phenotypes in 40 patients with spinal muscular atrophy: Observational study.
    Zhang Y; He J; Zhang Y; Li L; Tang X; Wang L; Guo J; Jin C; Tighe S; Zhang Y; Zhu Y; Zhu B
    Medicine (Baltimore); 2020 Jan; 99(3):e18809. PubMed ID: 32011487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between the SMN2 gene copy number and clinical characteristics of patients with spinal muscular atrophy with homozygous deletion of exon 7 of the SMN1 gene.
    Zarkov M; Stojadinović A; Sekulić S; Barjaktarović I; Perić S; Keković G; Drasković B; Stević Z
    Vojnosanit Pregl; 2015 Oct; 72(10):859-63. PubMed ID: 26665550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A paucisymptomatic neuromuscular disease mimicking type III 5q-SMA with complex rearrangements in the SMN gene.
    Lohkamp LN; von Au K; Goebel HH; Kress W; Grieben U; Drossel K; Garbes L; Wirth B; Heppner FL; Stenzel W
    J Child Neurol; 2014 Feb; 29(2):254-9. PubMed ID: 24334346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypes of SMA patients retaining SMN1 with intragenic mutation.
    Wijaya YOS; Ar Rohmah M; Niba ETE; Morisada N; Noguchi Y; Hidaka Y; Ozasa S; Inoue T; Shimazu T; Takahashi Y; Tozawa T; Chiyonobu T; Inoue T; Shiroshita T; Yokoyama A; Okamoto K; Awano H; Takeshima Y; Saito T; Saito K; Nishio H; Shinohara M
    Brain Dev; 2021 Aug; 43(7):745-758. PubMed ID: 33892995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mutation analysis of SMN1 gene in patients with spinal muscular atrophy].
    DU J; Qu YJ; Xiong H; Li EZ; Jin YW; Bai JL; Wang H; Song F
    Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):411-5. PubMed ID: 21924051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling.
    Wirth B; Herz M; Wetter A; Moskau S; Hahnen E; Rudnik-Schöneborn S; Wienker T; Zerres K
    Am J Hum Genet; 1999 May; 64(5):1340-56. PubMed ID: 10205265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic Testing for Patients with Spinal Muscular Atrophy.
    Brandsema JF; Gross BN; Matesanz SE
    Clin Lab Med; 2020 Sep; 40(3):357-367. PubMed ID: 32718505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.